Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.3.1 (alkaline phosphatase)
 47,916 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Radiographic skeletal examinations were performed in eight adult patients who had received the aromatic retinoid etretinate for various disorders of keratinization over periods ranging from 1 to 7 years. Age- and sex-matched controls were also examined. In all patients, alterations of ossification were found to a varying degree, including calcification of the anterior spinal ligament, vertebral hyperostoses at the anterosuperior and anteroinferior margins of the vertebral bodies, unilateral bridging of vertebral bodies, hyperostoses of the calcanei at the insertion of the plantar ligament and bone accretion at the anterolateral lips of the acetabula. All the bone changes were asymptomatic. Serum calcium, inorganic phosphate, alkaline phosphatase, calcitonin and parathormone were within normal physiological ranges. In general, the bone changes observed after long-term etretinate treatment closely resembled the effects of isotretinoin on the skeleton.
Br J Dermatol 1987 Feb
PMID:Retrospective radiographic study of skeletal changes after long-term etretinate therapy. 382 15

The dorsal resting hair of C3H mice at various ages was shaved, thus activating the hair into the anagen stage. New hair growth after shaving was not uniform in the various age groups. Furthermore, an increasing delay in hair regrowth was observed as the mice became older (20, 66, 188, and 312 days). In the biochemical analysis of hair regrowing and nongrowing skins after shaving, activities of ornithine decarboxylase, transglutaminase, and alkaline phosphatase had higher values in the extract of the hair regrowing area compared with that in the nongrowing area. In studying the effects of various physical and chemical treatments on hair growth after shaving, repeated shaving was in itself clearly shown to stimulate hair growth. Amongst all of the treatments that were applied, topical application of TPA was most able to accelerate hair regrowth, followed by UV irradiation and retinoic acid treatment. Suppression of hair regrowth was observed in PUVA, DHT, and estradiol; and complete inhibition was seen in the animals treated with betamethasone valerate. In biochemical studies, a relatively good correlation was observed between the rate of hair regrowth and skin ODC activities after treatment.
Curr Probl Dermatol 1983
PMID:Regulation mechanisms of hair growth. 614 Jan 29

A patient with pyoderma gangrenosum without associated disease was studied. Routine investigations showed several abnormalities. High ESR, high alkaline phosphatase and glutamyl transferase (gamma-GT) levels, low iron and iron binding capacity, altered protein spectrum, presence of Staphylococcus aureus and group G hemolytic streptococci in ulcer culture, higher than normal antistreptolysin titers in the serum, and perivascular infiltration in the skin. Biochemical investigations aimed at finding any excessive hydrolytic activity did not reveal the presence of neutral proteases in circulation leaked out from PMN-leukocytes or elsewhere. Lysozyme levels were higher than normal, amylase and lipase levels were normal and 5' nucleotidase levels were below normal range. TCA-soluble polypeptides were present in the serum at levels two times higher than those in normal individuals. Immunochemical investigations showed the absence of immune complexes in the serum but presence of high amounts of C-reactive protein. Total complement activity was higher than normal and so was C3c level. Clq, C4, and C3d levels were within normal range. Biologic studies showed the presence of a factor in patient serum that made guinea pig skin hard, painful, erythematous, and eventually hairless, but not necrotic. A similar factor was either absent in normal serum or present in very low concentration. After salazopyrine treatment, all the above mentioned abnormalities corrected except that 5' nucleotidase activity remained slightly lower than normal, alkaline phosphatase levels remained slightly higher than normal, and C-reactive protein levels remained very high, though lower than those during intense disease activity.
Int J Dermatol 1984 Mar
PMID:Immunologic and biochemical studies on a patient with pyoderma gangrenosum. 614 8

In histiocytomas the alkaline phosphatase technique reveals a surprising number of capillaries. The capillaries branch out from the center to the periphery of the histiocytoma and even the capillaries beneath the epidermis proliferate. The cellular elements outside the capillaries, however, are fibroblasts, histiocytes and mast cells, as is revealed by various histochemical and electron microscopical examinations. Histiocytomas of short duration differ from older histiocytomas in that the former contain fibroblasts similar to those found in healing wounds (C-fibroblasts).
Arch Dermatol Res 1980
PMID:[Histochemical and electron microscopical studies of histiocytoma (author's transl)]. 624 81

Alkaline phosphatase was used in an immuno-enzymatic procedure to detect tissue-bound and circulating antibodies in pemphigus vulgaris. Pemphigus antibodies were revealed by a direct method using alkaline phosphatase conjugated goat anti-human IgG. Cryostat sections were incubated with the specific antiserum, and alkaline phosphatase activity was then revealed histochemically either by Gomori's technique or by the azo dye method. The sections were examined by light microscopy and intercellular staining was demonstrated in the epidermis. The indirect method, in which the patient's serum was incubated with sections of normal skin, gave similar results. Using parallel sections, an immunofluorescent technique was used to demonstrate tissue-bound and circulating antibodies. The alkaline phosphatase method appeared to be slightly less sensitive than the immunofluorescent method.
Br J Dermatol 1983 Jan
PMID:Alkaline phosphatase immuno-enzymatic technique in the diagnosis of pemphigus vulgaris. 633 46

Monoclonal immunoglobulin-producing lymphomas (immunocytomas, plasmacytomas, and immunoblastomas) constitute 15 to 20% of all cutaneous lymphomas. Their differentiation from polymorphous lymphoplasmacytoid inflammatory or pseudolymphomatous infiltrates may be difficult if sections are stained for a single light chain only. It was the aim of the study to elucidate the ratio of the kappa- to lambda-positive cells in 10 lymphoproliferative, 5 pseudolymphomatous, and 42 inflammatory lymphoplasmacytoid cutaneous infiltrates and to characterize them by the type of Ig (alpha, gamma, mu, kappa, or lambda) synthesized intracellularly. An indirect immunoenzymatic double-labeling method (alkaline phosphatase and peroxidase) was used for the simultaneous demonstration of kappa and lambda light chains and alpha, gamma, and mu heavy chains in paraffin sections. Ig-producing lymphomas of the skin show patchy monoclonal proliferations of cells synthesizing kappa IgM in almost 50% of the cases (5 of 10). Monoclonality is claimed if the ratio of lambda- to kappa-positive cells is at least 1:10, or vice versa. In polyclonal inflammatory and pseudolymphomatous infiltrates, the lambda/kappa ratio never exceeds 1:5. The most common cell type found in these reactive infiltrates produces gamma heavy chain; some produce alpha chain, but only a few produce mu chain. In high-grade malignant lymphomas, the tumor cells may lose their capacity for Ig production.
J Dermatol Surg Oncol 1984 Apr
PMID:Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. 642 9

In Sinclair swine, there is an increase in alkaline phosphatase activity in spontaneously arising melanoma tumors when compared to normal skin. While alkaline phosphatase activity could be detected in melanomas from animals 1 day old, the maximum levels of alkaline phosphatase activity occurred in tumors from animals greater than 30 days old. The alkaline phosphatase was purified from cutaneous melanomas using chloroform precipitation, Phenyl-Sepharose chromatography, and concanavalin A Sepharose chromatography approximately 146-fold, with an overall recovery of 15%. The purified enzyme exhibited optimal activity over the pH range of 8.9-10.6. The apparent Km of the enzyme for p-nitrophenyl phosphate was 0.15 mM. The enzyme exhibited a relative mobility of 0.04 in nondenaturing polyacrylamide gels. The molecular weight of the enzyme was estimated by gel filtration chromatography to be 122,000 and it was composed of two identical subunits each having a molecular weight of 67,000. The enzyme was thermolabile at 56 degrees C (T50, 18 min) and its activity was inhibited by L-homoarginine, levamisole, and vanadate, but not by L-phenylalanine or L-phenylalanylglycylglycine. These characteristics distinguished the enzyme from the intestinal isoenzyme that is found in normal swine skin but were similar to those exhibited by the porcine placental isoenzyme of alkaline phosphatase. These results suggest that the development of malignant melanoma in Sinclair swine is accompanied by the expression of a placental-like alkaline phosphatase activity.
J Invest Dermatol 1984 May
PMID:Properties of an alkaline phosphatase from Sinclair swine melanoma. 651 73

Alkaline phosphatase enzyme activity was studied histochemically in 60 non-Hodgkin lymphomas and 10 pseudolymphomas of the skin. Among the 37 B-cell lymphomas, membrane-bound alkaline phosphatase activity was demonstrated in 8 cases. In none of the 23 cutaneous T-cell lymphomas studied could membrane-bound alkaline phosphatase be detected. Among the pseudolymphomas, 2 cases revealed alkaline phosphatase activity. It was not possible to draw any particular clinically significant conclusions from the membrane-bound alkaline phosphatase reactions. Looking for the microenvironmental conditions of lymphoproliferative processes in the skin, alkaline phosphatase-positive capillaries were seen predominantly in the T-cell lymphomas. The stromal reaction showing a proliferation of alkaline phosphatase-positive fibroblasts was more pronounced in cutaneous B-cell lymphomas. In conclusion, membrane-bound alkaline phosphatase in lymphoproliferative processes in the skin, as in the lymph node, characterize a distinct group of B lymphocytes related to follicle center cells. The clinical relevance of this finding remains to be determined.
J Dermatol Surg Oncol 1984 Apr
PMID:Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. 660 43

Test sites on healthy controls and on the clinically uninvolved skin of psoriatic patients were stripped with tape, and eight variables were quantified at intervals during the subsequent healing process. In the control groups, the stratum corneum regenerated at a constant rate and the underlying skin showed elevations of metabolic activity peaking around days 2-4. In the psoriatic groups, we observed that (I) the response of the keratinizing zone is identical to that of the controls, (2) the proliferative response is initially normal but remains elevated rather longer than usual, and (3) the dermal capillaries (indicated by alkaline phosphatase activity) show a gross hyper-reactivity which is already apparent after 1 day and which persists for more than a week. These findings support our previous conclusion that metabolic alteration of the dermal capillary precedes epidermal hyperplasia in the pathogenesis of the psoriatic lesion.
Br J Dermatol 1983 Sep
PMID:Response of the clinically uninvolved skin of psoriatic patients to standardized injury. 661 16

Seventeen patients with palmoplantar pustular psoriasis and three with hyperkeratotic psoriasis of palms and soles were treated with either PUVA-etretinate (1 mg/kg) or PUVA-placebo. Patients were randomly allocated to each group and the trial was conducted according to a double-blind protocol, so far as the side-effects of etretinate made this possible. PUVA was given three times a week for a maximum of 18 weeks, after 2 weeks on daily placebo or etretinate alone. All ten patients in the PUVA-etretinate group cleared, but there were four failures in the PUVA-placebo group (P = 0.03). The PUVA-etretinate treated patients required significantly fewer PUVA treatments (13.1 +/- 2.9; mean +/- s.e.) and cleared in a significantly shorter time (30.3 +/- 7.1 days) than the PUVA-placebo group (23.2 +/- 4.2 treatments; 59.2 +/- 11.5 days, P less than 0.05). The cumulative UV-A dose to clear was less in the PUVA-etretinate group (53.9 +/- 18.5 J/cm2) than the PUVA-placebo group (113.1 +/- 33.4 J/cm2). This difference was not significant due to the exceptionally large dose of UV-A used on one patient but the results were significant when it was excluded. The therapeutic advantage of adding etretinate to PUVA is offset by the side-effects of cheilitis, hair loss and peeling skin which occurred in eight of the ten PUVA-etretinate patients, and an increase in fasting triglyceride concentrations and serum alkaline phosphatase activity.
Br J Dermatol 1984 Feb
PMID:A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. 669 38


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>